{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:19:28Z","timestamp":1761513568774},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.steroids.2014.12.016","type":"journal-article","created":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T17:04:13Z","timestamp":1420218253000},"page":"88-95","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Discovery of a novel isoxazoline derivative of prednisolone endowed with a robust anti-inflammatory profile and suitable for topical pulmonary administration"],"prefix":"10.1016","volume":"95","author":[{"given":"E.","family":"Ghidini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Carnini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Cenacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Marchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Virdis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Italia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2014.12.016_b0005","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bjo.82.6.704","article-title":"Systemic corticosteroid therapy-side effects and their management","volume":"82","author":"Stanbury","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.steroids.2014.12.016_b0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3132\/pcrj.2007.00038","article-title":"The properties of inhaled corticosteroids: similarities and differences","volume":"16","author":"Barnes","year":"2007","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.steroids.2014.12.016_b0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MCP.0b013e32834dc51a","article-title":"Systemic effects of inhaled corticosteroids","volume":"18","author":"Ernst","year":"2012","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.steroids.2014.12.016_b0020","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/jm00006a026","article-title":"New steroidal anti-inflammatory antedrugs: steroidal [16,17-d]-3-carbethoxyisoxazolines","volume":"38","author":"Kwon","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.steroids.2014.12.016_b0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.steroids.2005.10.003","article-title":"In vitro anti-inflammatory activities of new steroidal antedrugs: [16\u03b1,17\u03b1-d] Isoxazoline and [16\u03b1,17\u03b1-d]-3-hydroxy-iminoformyl isoxazoline derivatives of prednisolone and 9\u03b1-fluoroprednisolone","volume":"71","author":"Kwan-k","year":"2006","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2014.12.016_b0030","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0040-4020(99)01047-9","volume":"56","author":"Kanemasa","year":"2000","journal-title":"Tetrahedron"},{"key":"10.1016\/j.steroids.2014.12.016_h0035","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/jm00006a026","volume":"38","author":"Kwon","year":"1995","journal-title":"J Med Chem"},{"issue":"42","key":"10.1016\/j.steroids.2014.12.016_h0040","doi-asserted-by":"crossref","first-page":"14317","DOI":"10.1016\/S0040-4020(97)00983-6","volume":"53","author":"Bacher","year":"1997","journal-title":"Tetrahedron"},{"key":"10.1016\/j.steroids.2014.12.016_b0040","unstructured":"Yuan L; Yanchang L; Jinlu L; Chaohui S CN 101177443 A 20080514."},{"key":"10.1016\/j.steroids.2014.12.016_b0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/adt.2006.4.263","article-title":"A homogeneous cell-based assay to measure nuclear translocation using beta-galactosidase enzyme fragment complementation","volume":"4","author":"Fung","year":"2006","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.steroids.2014.12.016_h0055","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/0006-2952(83)90469-0","article-title":"Structure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralocorticoid receptors in vitro and the antialdosterone activity in vivo","volume":"32","author":"Wambach","year":"1983","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.steroids.2014.12.016_h0060","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.HYP.30.5.1274","article-title":"Impaired cortisol binding to glucocorticoid receptors in hypertensive patients","volume":"30","author":"Mulatero","year":"1997","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.steroids.2014.12.016_b0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0092-8674(02)00817-6","article-title":"Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition","volume":"110","author":"Bledsoe","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.steroids.2014.12.016_b0060","unstructured":"[Schr\u00f6dinger, Maestro version 9.1 Schr\u00f6dinger, LLC, New York 2009 http:\/\/www.schrodinger.com\/."},{"key":"10.1016\/j.steroids.2014.12.016_b0065","unstructured":"ACD\/LogP v12, www.acdlabs.com."},{"key":"10.1016\/j.steroids.2014.12.016_b0070","unstructured":"Armani E, Ghidini E, Peretto I, Virdis A. Isoxazolidine derivatives WO 2011\/029547 A8."},{"key":"10.1016\/j.steroids.2014.12.016_b0075","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1021\/ja01505a017","article-title":"The reactions of primary nitroparaffins with isocyanates","volume":"2","author":"Mukaiyama","year":"1960","journal-title":"J Am Chem SOC"},{"key":"10.1016\/j.steroids.2014.12.016_b0080","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1021\/jo01280a023","article-title":"The decarboxylation of 3-carboxy-2-isoxazolines. 3\u03b2,17\u03b1-dihydroxypregna5-en-20-one-16\u03b1-carbonitrile","volume":"32","author":"Moersch","year":"1967","journal-title":"J Org Chem"},{"key":"10.1016\/j.steroids.2014.12.016_b0085","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/jo01015a524","article-title":"The decarboxylation of 3-carboxy-2-isoxazolines","volume":"30","author":"Moersch","year":"1966","journal-title":"J Org Chem"},{"key":"10.1016\/j.steroids.2014.12.016_b0090","doi-asserted-by":"crossref","first-page":"e64257","DOI":"10.1371\/journal.pone.0064257","article-title":"Evaluation of glucocorticoid receptor function in COPD lung macrophages using beclomethasone-17-monopropionate","volume":"8","author":"Plumb","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.steroids.2014.12.016_b0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/JME-08-0093","article-title":"Structure-function relationships in the mineralocorticoid receptor","volume":"41","author":"Pippal","year":"2008","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.steroids.2014.12.016_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/JOE-11-0372","article-title":"Mechanisms of ligand specificity of the mineralocorticoid receptor","volume":"213","author":"Fuller","year":"2012","journal-title":"J Endocrinol"},{"key":"10.1016\/j.steroids.2014.12.016_b0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1165\/ajrcmb.18.1.2813","article-title":"Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids","volume":"18","author":"John","year":"1998","journal-title":"Am J Resp Cell Mol"},{"key":"10.1016\/j.steroids.2014.12.016_b0110","doi-asserted-by":"crossref","first-page":"26803","DOI":"10.1074\/jbc.M109.028381","article-title":"Inhibition of NF-kB-dependent transcription by MKP-1","volume":"284","author":"King","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.steroids.2014.12.016_b0115","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1096\/fj.09-134684","article-title":"Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action","volume":"23","author":"Ayroldi","year":"2009","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.steroids.2014.12.016_h0130","first-page":"1208","volume":"16","author":"Hansch","year":"1973","journal-title":"J Med Chem"},{"key":"10.1016\/j.steroids.2014.12.016_h0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/qsar.19890080105","volume":"8","author":"Skagerberg","year":"1989","journal-title":"Quant Struct Act Relat"},{"issue":"12","key":"10.1016\/j.steroids.2014.12.016_b0125","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1016\/j.molimm.2007.01.029","article-title":"Regulation of the murine inducible nitric oxide synthase gene by dexamethasone involves a heterogeneous nuclear ribonucleoprotein I (hnRNPI) dependent pathway","volume":"44","author":"S\u00f6derberg","year":"2007","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.steroids.2014.12.016_b0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.abb.2007.01.006","article-title":"C-Phycocyanin inhibits 2-acetylaminofluorene-induced expression of MDR1 in mouse macrophage cells: ROS mediated pathway determined via combination of experimental and in silico analysis","volume":"459","author":"Roy","year":"2007","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.steroids.2014.12.016_b0135","first-page":"14","article-title":"P-glycoprotein expression in circulating blood leukocytes of patients with steroid-resistant asthma","volume":"6","author":"Montano","year":"1996","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.steroids.2014.12.016_b0140","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1476-5381.2011.01620.x","article-title":"Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide","volume":"165","author":"Kelly","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.steroids.2014.12.016_b0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pupt.2007.01.001","article-title":"Dose-dependent inhibition of allergic inflammation and bronchial hyperresponsiveness by budesonide in ovalbumin-sensitised Brown-Norway rats","volume":"21","author":"Leung","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.steroids.2014.12.016_b0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-2999(02)01295-5","article-title":"Effect of topical immunomodulators on acute allergen inflammation and bronchial hyperresponsiveness in sensitised rats","volume":"437","author":"Huang","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.steroids.2014.12.016_b0155","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pupt.2005.09.002","article-title":"Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors","volume":"19","author":"Wollin","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.steroids.2014.12.016_b0160","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejphar.2010.06.054","article-title":"Pharmacology of a potent and selective inhibitor of PDE4 for inhaled administration","volume":"643","author":"Chapman","year":"2010","journal-title":"Eur J Pharmacol"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14003092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14003092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T01:15:33Z","timestamp":1566177333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X14003092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":35,"alternative-id":["S0039128X14003092"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2014.12.016","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel isoxazoline derivative of prednisolone endowed with a robust anti-inflammatory profile and suitable for topical pulmonary administration","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2014.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}